Millions more senior citizens and lower-income Americans could soon have access to costly anti-obesity drugs under a new proposal by the Biden administration. The plan, announced on Tuesday, aims to provide coverage for approximately 3.4 million Medicare beneficiaries and 4 million Medicaid recipients, who currently face high out-of-pocket expenses for these medications.
The White House highlighted that some Medicare enrollees could see a significant reduction in their out-of-pocket costs, potentially up to 95%. This initiative is intended to empower individuals and their healthcare providers to make informed decisions about their health without financial barriers.
